Briefly, NAFLD remains one of the major characteristic features of metabolic syndrome [43], and this condition is persistent with the rise in hepatic enzymes such as alanine transaminase and aspartate transaminase (AST). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.